Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial

Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added the Drug Saf. 2021 article citation with an erratum and updated the revision label from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T04:54:29.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0, reflecting a new version tag rather than content changes.
    Difference
    0.1%
    Check dated 2026-03-22T08:51:13.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. This change does not affect the study information or user workflows.
    Difference
    0.1%
    Check dated 2026-03-07T18:05:37.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No substantive changes to the study details or page layout are visible.
    Difference
    0.1%
    Check dated 2026-02-14T05:42:33.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-07T05:22:36.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Plain language trial summaries are now available on novctrd.com and 2026 update entries have been added; these changes are informational and do not affect core trial details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-31T02:56:29.000Z thumbnail image

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.